Ongoing research from our group, presented at Breaking Convention 2019: https://www.youtube.com/watch?v=URSqxFocaas 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychotropic substance found in various plant as well as animal species, and can also be synthetically produced. Despite the use of 5-MeO-DMT by people in naturalistic settings, current scientific knowledge on the effects of 5-MeO-DMT in humans are relatively… Continue reading Prospective Examination of Synthetic 5-methoxy-N,N-dimethyltryptamine Inhalation
Category: Videos
(Sub-)Acute Effects of Psilocybin on Creativity, Empathy and Satisfaction with Life
Ongoing research from our group, presented at Breaking Convention 2019: https://www.youtube.com/watch?v=KEGJWxH-jYs Creative thinking and empathy are crucial for everyday interactions and subjective well-being. This is emphasised by studies showing a reduction in these skills in populations where social interaction and subjective well-being is significantly compromised (e.g. depression). Anecdotal reports and recent studies suggest a single… Continue reading (Sub-)Acute Effects of Psilocybin on Creativity, Empathy and Satisfaction with Life
MDMA- and psilocybin-assisted therapy discussion panel, Helsinki, Finland
Dr. Kim Kuypers and Natasha Mason were invited to speak at and participate in an event in Helsinki, Finland, discussing research on the therapeutic potential and mechanisms of action of psilocybin and MDMA. The panel discussion has now been posted, and can be viewed here.
Psychedelics & Cognitive Flexibility: Therapeutic Implications – Natasha Mason
Amsterdam Psychedelic Research Association 02/06/18 In the last decade, there has been a renewed scientific interest in the utility of psychedelics. Increasing evidence suggests that psychedelics like ayahuasca and psilocybin may have potential therapeutic value for disorders like depression, PTSD, and anxiety. The focus of such investigations has been on psychedelics capacity to reduce symptoms… Continue reading Psychedelics & Cognitive Flexibility: Therapeutic Implications – Natasha Mason
Regel je straks MDMA bij de psychiater in plaats van bij de dealer?
Het klinkt nu misschien nog raar, maar in de nabije toekomst zou je bij de psychiater best wel eens een dosis MDMA kunnen krijgen. Dit heeft alles te maken met de stoffen die het vrij maakt in je hersenen. Jan Ramaekers (Maastricht University) legt het je uit. Find video here (in Dutch) Universiteit van Nederland… Continue reading Regel je straks MDMA bij de psychiater in plaats van bij de dealer?
